NCT07613723 A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies Status RECRUITING Phase PHASE1
NCT07612891 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor Status RECRUITING Phase PHASE1/PHASE2
NCT07610798 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07609082 Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer Surgery Status NOT_YET_RECRUITING Phase NA
NCT07593833 Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection Status NOT_YET_RECRUITING Phase N/A
NCT07593092 Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07586826 Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors Status RECRUITING Phase PHASE2
NCT07572409 Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study Status RECRUITING Phase NA
NCT07567573 Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery Status COMPLETED Phase N/A
NCT07564141 Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07555639 An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity Status ACTIVE_NOT_RECRUITING Phase NA
NCT07555600 Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase NA
NCT07546578 Setting Up ctDNA Analysis on Archived Plasma Samples Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07546500 A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression Status RECRUITING Phase PHASE3
NCT07544030 A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer Status RECRUITING Phase PHASE3
NCT07540403 Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinoma Status RECRUITING Phase N/A
NCT07539844 Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries Status NOT_YET_RECRUITING Phase N/A
NCT07532434 A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer Status RECRUITING Phase N/A
NCT07532148 Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status NOT_YET_RECRUITING Phase PHASE1